Background & Aims: Liver fibrosis is the outcome of chronic liver injury. Transforming
| INTRODUCTION
Chronic injury leads to scarring of the liver, causing loss of function and multiple complications such as oesophageal bleedings and cancer. Ongoing liver injury causes fibrosis of liver tissue by extracellular matrix (ECM) deposition.
1 Hepatic stellate cell(s) (HSC) are the major source of Collagen and ECM production. In response to liver injury, HSC undergo activation from quiescent HSC to activated myofibroblasts. 2 Because of their embryonic origin, HSC express neural markers (Glial fibrillary acidic protein [GFAP] , Synemin and Synaptophysin) along with mesenchymal markers (Desmin, Vimentin). Activation of HSC is regulated by many pro-and antifibrotic cytokines.
Transforming growth factor-β (TGF-β) is a major profibrotic cytokine, signalling through a network of receptors and intracellular mediators. Endoglin is a type III TGF-β receptor which is highly expressed on proliferating vascular endothelial cells, 3, 4 cardiac and scleroderma fibroblasts, 3 macrophages 5 and HSC. 3, 6 In the presence of TGF-β receptors, type I and type II Endoglin binds different ligands of the TGF-β super-family mediating Smad-dependent and independent signalling. Therefore, most data rely on endothelial cell biology and claim that Endoglin modulates the balance between TGF-β1-ALK1 and TGF-β1-ALK5 signalling pathways. 11 L-Endoglin promotes cell proliferation via TGF-β1-ALK1 signalling, while interfering with the TGF-β1-ALK5 pathway whereas S-Endoglin activates the TGF-β1-ALK5 pathway.
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In HSC, the TGF-β1/ALK5 signalling pathway generally regulates key profibrogenic responses. 13 However, it has been shown that the TGF-β1/ALK1/Id1 pathway is also involved in profibrogenic signalling.
14 Nevertheless, although Endolin is highly expressed in HSC, in vivo data analysing Endoglin function in fibrosis are missing.
Because of its interactions with TGF-β signalling, Endoglin expression can be linked to various pathological conditions such as cancer,
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cancer angiogenesis 16 and fibrosis in different organs. 17 In the process of kidney fibrosis, Endoglin is upregulated in human patients and in animal disease models. However, the impact of Endoglin is not clear.
Most in vitro studies imply an antifibrotic effect of Endoglin, 18 experiments using overexpression of full length Endoglin in HSC cell lines imply a profibrogenic role. 19, 20 The insight in the role of Endoglin in liver disease is limited. In hepatitis C infection or liver fibrosis/cirrhosis, high levels of sol-Eng were detected.
Endoglin expression is upregulated in murine liver disease models and in hepatic stellate cells. 20 In addition, overexpression of L-Endoglin in HSC cell lines of rat and mouse origin shows that Endoglin modulates TGF-β1
signalling. 19, 20 The relation of Endoglin and TGF-β, the expression on HSCs and its expression in fibrotic diseases makes it an interesting target to study its impact on TGF-β signalling in chronic liver injury.
| METHODS

| Animal models
The mouse line expressing the floxed endoglin gene was generated by Arthur et al 21 at the Institute of Human Genetics, International
Centre for Life, University of Newcastle upon Tyne, UK and has a C57BL/6 background. The GFAP Cre mouse used in this study was ordered at Jackson Labs and backcrossed to a C57Bl/6 background (FVB-Tg(GFAP-cre)25Mes/J, stock no. 004600).
| Human samples
Human liver samples (n = 6/group) were obtained from patients undergoing biopsy for diagnostic medical reasons after obtaining informed consent in accordance to the ethical guidelines of the 1975 Declaration of Helsinki. The study was approved by the "Ethic Regulations Committee of the University Hospital RWTH Aachen".
The analysed material was excess biopsy material not used for further diagnostics, biopsies were not taken for study purposes only.
| Isolation of primary liver cells
Quiescent HSCs, KCs and liver sinusoidal endothelial cell(s) (LSECs)
were isolated from untreated mice by the two step pronase-collagenase method. 22 HSCs were further purified by a single-step density gradient centrifugation and sorted by retinoid-dependent FACS analysis.
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KEY POINTS
• Endoglin is expressed and upregulated in human samples of acute and chronic liver disease.
• Hepatic stellate cells, the major extracellular matrix producing cell in liver injury show significant expression of Endoglin.
• Hepatic stellate cell-specific deletion in murine models of liver fibrosis leads to aggravation of liver fibrosis-suggesting a protective effect of Endoglin on TGF-β signalling in liver injury.
• Although depletion of Endoglin in HSC leads to a decrease in matrix accumulation in the affected liver in vivo,
Endoglin promotes profibrogenic aspects in vitro.
| Induction of liver fibrosis
Wild-type C57BL/6 (n = 8), GFAP For additional methods, see Appendix S1. For antibodies used in this study, see Table S1 .
| RESULTS
| Endoglin splice variants show differentially increased expression in livers of patients with acute and chronic disease
Liver biopsies from patients with acute liver failure (ALF) and chronic liver injury (ie, non-alcoholic steatohepatitis [NASH] and HCV infection) were analysed for Eng mRNA expression. Figure 1A shows significantly (P < .05) increased L-Eng expression in ALF as well as in chronic liver injury compared to healthy control livers. However, the S-Eng levels were only increased in ALF patients and not in patients with chronic liver diseases suffering from NASH or HCV infection ( Figure 1B ).
| Endoglin splice variants are expressed in mouse tissues and isolated liver cells L-and S-Endoglin expression was analysed in various mouse tissues and in isolated primary liver cells. L-Endoglin is the predominantly expressed isoform in all examined tissues as well as in KC, LSEC and
HSCs. S-Endoglin is also present in significant levels in all tissues and liver cells tested ( Figure 1C ,D). Hepatocytes do not express Endoglin.
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Liver injury after BDL resulted in significant L-/S-Endoglin upregulation compared to sham-operated mice. Of interest, especially S-Endoglin expression is upregulated more pronounced early after injury, in the second and third week after BDL both isoforms were highly expressed compared to controls ( Figure 1E ). Similar effects were seen in CCl 4 treated animals (data not shown).
| GFAP Cre specifically targets HSCs
In order to analyse the contribution of Endoglin to liver fibrosis in vivo, mice with a floxed endoglin gene were crossed with GFAP Cre animals.
Because of their developmental lineage, HSCs are the only GFAPexpressing cells in the liver. Results are means ± SEM of three mice per group (*P < .05, ***P < .001).
(E), Expression of endoglin mRNA in whole liver tissue from C57BL/6 wild-type mice which underwent bile duct ligation (BDL) for 3 wk. Especially, S-endoglin expression is upregulated in cholestatic liver injury. Data are expressed as means ± SEM of 3 mice per group (*P < .05, **P < .01) ) exons 5 and 6 of the endoglin gene are flanked by lox-P sites, so that the above mentioned primer pairs amplify a product of 500 and 566 bp, respectively, in cells which do not express the Cre transgene. Upon Cre-mediated recombination in HSC, the floxed exons 5 and 6 of endoglin are deleted which results in an amplification product of 602 bp using primers x/y (n = 3). Since the deletion is not quantitative, the products of the floxed gene without deletion are also amplified to a lower content from Cre positive HSC. Furthermore, these results suggest that HSCs contribute to systemic sol-End levels in liver injury. Figure 5 ). mRNA expression of fibrotic markers such as Collagen α1(I) and α-SMA showed higher expression levels in GFAP Cre(+) Eng ΔHSC livers in both injury models. Even though mRNA expression results slightly missed significance levels (P = .057-.073) in synopsis with above mentioned histological long-term findings, these results confirm increased fibrogenesis after endoglin deletion in HSCs.
| HSC-specific endoglin deletion in liver injury leads to aggravation of liver fibrosis
| Endoglin-deficient primary HSCs express more fibrogenic proteins
After in vivo experiments showed a protective role of Endoglin in HSC during fibrogenesis, TGF-β1 signalling in isolated primary HSC was analysed in vitro. Primary HSC were isolated from Eng f/f mouse livers and infected with adenoviral Cre or a control virus expressing luciferase. Cre-induced deletion of floxed Eng resulted in a strong reduction of Eng mRNA and protein expression ( Figure 6A ,B, Table S1 ), which is more potent than the partial deletion caused by endogenous Cre-expression (cf. Figure 2A Table S1 ) and the siRNA-treated HSC Col-GFP cell line ( Figure 6C , Table S1 ). However, TGF-β1-mediated expression and the secretion of the profibrogenic matricellular protein 
| DISCUSSION
There are many reviews discussing TGF-β signalling and its impact on fibrosis development. 29, 30 Especially TGF-β1 is known to play a pivotal role in fibrosis development. Already Kanzler and colleagues generated transgenic mice overexpressing a fusion gene consisting of the cDNA coding for an activated form of TGF-β1 controlled by the regulatory shown elevated serum and tissue Endoglin levels. 15, 35 In the present study, we found an elevation of the L-Endoglin isoform mRNA in human liver biopsy samples of ALF and chronic HCV infection. In contrast, transcripts of S-Endoglin were increased in ALF but not in HCV-infected patients. These findings show a differential regulation of both isoforms.
This is pivotal for evaluating Endoglin function since both isoforms
show opposing effects in vitro and in vivo and underscore the critical role of the intracellular domain which differs in both splice variants. 11, 36 RT-PCR analysis shows that both splice variants are co-expressed in all tissues tested and that the L-variant is the predominantly expressed form. This finding is in line with a previous report confirming the high organ expression of the L-form compared to the varying but low expression of the S-form. 37 This ratio has been of vital importance for cells since a change in endothelial cells has caused cellular senescence. 46 In addition to the direct effects on HSC, depletion of Endoglin leads to a reduced abundance of soluble Endoglin, and therefore to a modulation of the paracrine effects on hepatocytes for example which might also impact the outcome of fibrosis.
In a follow-up study of our group performed with an ubiquitous endoglin knockout using an inducible CAG-Cre mouse endoglin deficiency showed no significant effects on inflammation, or the amount of liver injury in CCl 4 -exposed mice, suggesting that ENG-mediated TGF-β signalling is mainly involved in fibrosis and scarring (data not shown).
In summary, our present study shows a differential regulation of Endoglin isoforms in liver samples of patients with chronic and acute liver injury. In response to injury, liver fibrosis is aggravated by Endoglin deficiency in HSC significantly. Therefore, Endoglin protects against fibrotic injury by modulating TGF-β signalling.
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F I G U R E 6 Endoglin-deficient primary hepatic stellate cell (HSC) show increased fibrotic markers. (A), Quantitative analysis of Endoglin transcripts in primary HSC containing floxed Endoglin alleles infected with a Cre or luciferase (Luc) expressing virus and stimulated with transforming growth factor-β1 (TGF-β1) (1 ng/mL) for 48 h using the primers x/w. Note that the Endoglin mRNA is strongly reduced in Creexpressing cells compared to the Luc-expressing controls (n = 3). (B), left Western Blot analysis of proteins from isolated HSC with floxed Endoglin alleles, infected or not with adenovirus expressing Cre (see (A)). Cells were treated with a luciferase control adenovirus (Luc) or a Cre-expressing vector. Thereafter, cells were treated or not with TGF-β1 (1 ng/mL) in the presence or absence of the ALK5 inhibitor SB421543 (SB, 5 μmol/L) for 48 h and analysed by Western blot. Respective proteins were detected by the indicated specific antibodies. To demonstrate equal protein loading, the membrane was re-probed with a β-actin-specific antibody (n = 2). (B), right Representative densitometric analysis of the shown Western blot. The relative expression of the analysed proteins was normalized to β-actin. (C), left panels Western blot analysis of proteins from HSC Col-GFP treated with control siRNA (Luc) or endoglin-specific siRNA (Eng). The cells were treated with TGF-β1 (1 ng/mL) in the presence or absence of the ALK5 inhibitor SB421543 (SB, 5 μmol/L) for 1 h (upper left) or 48 h (lower left) and corresponding protein extracts were analysed by Western blot. Cells that were not stimulated with TGF-β1 served as controls. Respective proteins were detected by the indicated specific antibodies.
To demonstrate equal protein loading, the membrane was re-probed with a β-actin-specific antibody (n = 3). (C), right panels Representative densitometric analysis of the shown Western blots. The relative expression of the analysed proteins was normalized to β-actin
